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HSV Latency-Associated
Transcript and Neuronal
Apoptosis
In a study of the latency-associated transcript
(LAT ) gene in herpes simplex virus–type 1
(HSV-1), Perng et al. reported that “in rabbit
trigeminal ganglia [TGs], extensive apoptosis
occurred with LAT2 virus but not with LAT1
viruses,” and concluded that the LAT gene “pro-
motes neuronal survival after HSV-1 infection
by reducing apoptosis” (1). That conclusion
rested on interpretations of two in situ analyses:
(i) immunohistochemical staining for cleaved
poly (ADP-ribose) polymerase (p85 PARP),
and (ii) terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate nick-end
labeling (TUNEL) to detect fragmented DNA.
Cleavage of PARP by caspases between amino
acids 214 and 215 generates an 89-kD protein,
in an early and diagnostic event in apoptosis
(2). Perng et al. used a commercially available
antibody (Anti-PARP p85 fragment pAb kit;
Promega, Madison, Wisconsin) shown to be
specific for the cleaved form of human and
bovine PARP by Western blot analysis. Sur-
prisingly, however, we found no published re-
ports demonstrating that the same antibody is
reactive against the cleaved form of PARP in
rabbits, and our own Western blot and immu-
nohistochemical analyses (Fig. 1) revealed that
the antibody recognizes neither rabbit nor
mouse p89 PARP protein.
In our experiments, protein extracts were
produced from normal cells and from cells in-
duced to undergo apoptosis [apoptosis was con-
firmed by characteristic DNA laddering (Fig. 1)
and supported by positive TUNEL staining
(Fig. 2)]. The extracts were electrophoresed,
electroblotted, and probed with monoclonal an-
tibody C-2-10 (Calbiochem, La Jolla, Califor-
nia), which detects both the intact (116 kD) and
cleaved (89 kD) forms of PARP in bovine,
human, mouse, rat, monkey, and rabbit cells
(3), and with the Promega Anti-PARP p85 an-
tibody. All protein extracts reacted with C-2-10
to yield bands of the expected sizes, and
cleaved PARP was readily detected with C-2-
10 in extracts from mouse, rabbit, and human
cells undergoing apoptosis. By contrast, only
the human cell extracts reacted with Promega
Anti-PARP p85 (Fig. 1A). Likewise, when
Anti-PARP p85 was employed for immunohis-
tochemistry, only the apoptotic human cells
showed the characteristic intense nuclear stain-
ing (Fig. 1B). As expected, the C-2-10 antibody
stained both normal and apoptotic cells. We
note that Perng et al. reported cytoplasmic as
well as nuclear staining with Anti-PARP p85,
whereas cleaved PARP is localized to the nu-
cleus (4). We conclude that the signal detected
by Perng et al. was unrelated to p85 PARP.
The sequence of the peptide employed to
generate the Promega antibody is proprietary,
but it is presumably similar to the 19–amino
acid peptide originally reported by Sallmann et
al. (5). This peptide (amino acids 196 to 214 of
human PARP) is identical in human, bovine,
and chicken PARP but differs by three amino
acids in the mouse protein. The sequence of
rabbit PARP is not available, but the lack of
immunoreactivity strongly suggests that the
rabbit protein likewise contains differences in
the amino acid sequence of this region suffi-
cient to abrogate binding to Anti-PARP p85.
In a second in situ assay, Perng et al. used
the Klenow-FragEL DNA fragmentation detec-
tion kit (Oncogene, Cambridge, Massachusetts)
to detect fragmented DNA in apoptotic cells
(1). The high positive correlation (P , 0.05)
between the false positive signal obtained with
the rabbit polyclonal Anti-PARP p85 on rabbit
tissues and the TUNEL-positive cells (1) sug-
gests that the TUNEL results may also have
been misinterpreted. Factors such as calcium
stores, active RNA transcription, and mRNA
splicing can result in positive TUNEL signals
that are unrelated to apoptosis (6). The subcel-
lular localization of a positive signal resulting
from fragmented DNA should be in the nucle-
us. However, the signal detected by Perng et al.
in TG neurons appears to be from the cyto-
plasm, an unlikely localization for signal orig-
inating from fragmented DNA.
We examined TUNEL staining in human,
mouse, and rabbit cells induced to undergo
apoptosis (Fig. 2, A to C), as well as in
sectioned rabbit TGs treated to serve as a
positive control for TUNEL, as suggested by
the kit manufacturer (Fig. 2, D to F). Positive
TUNEL signal shows up as strong nuclear
staining resembling the staining Perng et al.
observed in infiltrating immune cells [figure
Fig. 1. Tests of immu-
noreactivity of Pro-
mega Anti-PARP p85
antibody with cleaved
mouse, rabbit, and hu-
man PARP. (A) West-
ern blot test. Swiss
Webster mouse NIH/
3T3 cells [American
Type Culture Collec-
tion (ATCC)], primary
young rabbit kidney
(YRK) cells at passage
3, and human Hela
cells (ATCC) were in-
duced to undergo ap-
optosis by treatment
with staurosporine
(Stauro, 0.2 mM) for
3 hours or sorbital
(Sorb, 1 M) for 1 hour
followed by 2 hours in
normal medium. Both
methods of inducing
apoptosis yielded typi-
cal DNA fragmentation
patterns with all cell
types; right-hand panel
shows example from
YRK cells. Protein ex-
tracts were prepared,
electrophoresed under reducing/denaturing conditions, electroblotted onto nitrocellulose membranes,
and probed with the Calbiochem monoclonal antibody C-2-10 or with Promega Anti-PARP p85
essentially as described in (8). Extracts from cells that had undergone apoptosis (denoted by 1 symbol
in row labeled Apoptotic) all showed bands of the expected sizes, indicating presence of both intact (116
kD) and cleaved (89 kD) PARP, when tested with the C-2-10 antibody; by contrast, only the extract from
the apoptotic human cell line tested positive for cleaved PARP using the Promega Anti-PARP p85
antibody. Similar findings (not shown) were obtained with Balb/C 3T3 (another mouse cell line), rabbit
skin cells, and two additional human cell lines [HL60 and SK-N-SH neuroblastoma cells (ATCC)]. (B)
Immunohistochemical-staining test. Untreated cells (–) or cells induced to undergo apoptosis (1) using
staurosporine as described above were rinsed with phosphate-buffered saline solution, fixed with 4%
paraformaldehyde, and processed for immunohistochemical detection of PARP using C-2-10 or Anti-
PARP p85, as suggested by the manufacturers. Positive signal is seen as a brown precipitate. As in Fig.
1A, all cells show a positive PARP signal when tested with the Calbiochem antibody, but only apoptotic
human cells test positive with the Promega antibody.
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1C of (1)]. For comparison, two TUNEL
results shown by Perng et al. [figure 1, E
and F of (1)] are reproduced here at several
magnifications (Fig. 2, G to I). In figure 1E
of (1), a neuronal nucleus with a prominent
nucleolus is visible within a larger blue-
green region (arrow in Fig. 2G). Figure 1F
of (1), which shows a positive TUNEL
signal over the entire blue-green area of
several neurons (Fig. 2H), apparently ap-
pears in (1) at a magnification approxi-
mately 30% smaller than that of two other
panels from the same experiment (7 ).
When the figure is enlarged to a similar
magnification (Fig. 2I), the brown precipi-
tate detected in the neurons looks primarily
cytoplasmic, with what appears to be the
nucleus (arrow in Fig. 2I) largely devoid of
signal.
In summary, the antibody employed by
Perng et al. (1) to identify apoptotic rabbit
TG neurons does not recognize the cleaved
form of rabbit PARP. Although TUNEL-
positive cells were detected in rabbit TGs,
most if not all of the nuclear signal shown
appears to have been in infiltrating immune
cells, as would be expected during the res-
olution of any infection. Thus, the report by
Perng et al. (1) provides no evidence that
the HSV-1 LAT gene blocks virus-induced
apoptosis in neurons.
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Response: Thompson and Sawtell report that
the Promega Anti-PARP p85 antibody did
not recognize cleaved PARP in mouse or
rabbit cells in their experiments, and con-
clude that the results reported with this anti-
body by Perng et al. (1) are an artifact. The
Promega antibody was generated against a
peptide based on the sequence of human p85.
Although the corresponding bovine sequence
differs by two amino acids, the antibody re-
acts with both human and bovine p85 (2). The
mouse and rat sequences for this region of
p85 differ from the human sequence by a
single amino acid that corresponds to one of
the bovine amino acid differences. External
testers have successfully stained mouse and
rat p85 using Promega Anti-PARP p85 (2).
Thus, the negative mouse results reported by
Thompson and Sawtell are surprising, and
call into question the validity of their nega-
tive rabbit results.
Extracts that we prepared (Fig. 1) from
rabbit skin cells induced to undergo apoptosis
by staurosporin (lane RS-S) contained a band
of approximately 85 kD that was recognized
by Anti-PARP p85, and that comigrated with
the p85 band induced in human Jurkat cells
by staurosporin (lane Jurkat-S) or anti-Fas
antibody (lane Jurkat-F). Clearly, then, the
Promega antibody recognizes the rabbit
cleaved PARP p85 protein, and the argument
to the contrary by Thompson and Sawtell has
no merit. Their negative mouse and rabbit
results apparently stemmed from technical
problems, a bad batch of antibody, or some
other unknown factor.
Thompson and Sawtell also contend that
the Perng et al. results are incorrect because
immunohistochemical tests of some neurons
showed p85 staining in both the cytoplasm
and the nucleus, whereas cleaved PARP
should be found only in the nucleus. Howev-
er, the proteolytic cleavage product of PARP
has been detected immunocytochemically
and confirmed by Western analysis both in
the nuclei and in the cytoplasm of cells in a
human osteosarcoma cell line that has under-
Fig. 2. TUNEL staining for fragmented DNA. Left panels: Additional cultures from (A) human, (B)
mouse, and (C) rabbit cell lines tested in Fig. 1 were processed for TUNEL according to instructions
by the manufacturer (Promega). Cells were rarely positive in the absence of treatment, but the
number of positive cells increased dramatically in cultures induced to undergo apoptosis. Positive
signal is seen as a brown precipitate confined to the nucleus. Central panels: Rabbit TGs [(D) to (F)]
were obtained at necropsy, drop-fixed in 4% paraformaldehyde, and processed as a positive control
for TUNEL as described by the manufacturer (Promega). Magnifications are similar to those
described for figure 1 of (1). Positive signal is seen as a brown precipitate confined to the nucleus.
Right panels: Details from figure 1 of (1). (G) Figure 1E of (1) shows area interpreted as neuronal
nucleus with prominent nucleolus (arrow) within larger blue-green area interpreted as cytoplasm.
(H) Figure 1F of (1), at original magnification. Brown dots are TUNEL-positive regions. (I) Figure 1F
of (1), at increased magnification. TUNEL-positive areas appear to be largely confined to area
interpreted as cytoplasm, with little signal in area interpreted as nucleus (arrow).
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gone apoptosis in culture (3). Cytoplasmic
staining for PARP has also been reported in
groups of neurons in the human central ner-
vous system (4 ). Thus, contrary to the asser-
tion by Thompson and Sawtell, cleaved
PARP can be found both in the cytoplasm
and the nucleus during apoptosis.
In a similar vein, Thompson and Sawtell
argue that DNA fragmentation indicated by
TUNEL staining should be limited to the
nucleus. A number of lines of evidence, how-
ever, strongly suggest that fragmented DNA
and TUNEL staining can occur in the cyto-
plasm as well. In primary human keratino-
cytes and also in other cells undergoing apo-
ptosis, cleaved DNA is extruded into the
medium (5); the cleaved DNA obviously
must pass through the cytoplasm to get out of
the cell. In apoptotic cells in the developing
retina of rabbits, rats, and cats, TUNEL stain-
ing labeled the cytoplasm (6 ), an indication
that DNA fragments spread into the cyto-
plasm of the dying cell. In brains of
Creutzfeldt-Jakob disease victims, nuclear
DNA leakage produced positive TUNEL
staining in the cytoplasm of some cells (7 ).
TGs of newborn rats injected with capsaicin
to induce apoptosis and DNA fragmentation
showed a TUNEL signal that had spread from
the neuronal nucleus to the cytoplasm (8).
The instructions in the commercially avail-
able kit Cell Death Detection ELISA (Cat.
No. 1 544 675, Roche, Mannheim, Germa-
ny), which detects apoptosis based on the
presence of cytoplasmic histone-associated
DNA fragments, state that “enrichment of
mono- and oligonucleosomes in the cyto-
plasm of the apoptotic cell is due to the fact
that DNA degradation occurs several hours
before plasma membrane breakdown.” Final-
ly, HSV-1, the subject of the Perng et al. (1)
study, buds through the nuclear membrane, a
situation that may make the nuclear mem-
brane more susceptible to leakage of frag-
mented DNA.
In the TUNEL controls of Thompson and
Sawtell (their figure 2, D to F), none of the
digested DNA moved out of the nucleus,
because these cells were fixed before de-
oxyribonuclease (DNase) treatment. In con-
trast, when the DNA is fragmented in live
cells undergoing apoptosis, small DNA frag-
ments can exit the nucleus and be stained in
the cytoplasm. (The DNase control is intend-
ed to show that the kit reagents are function-
ing properly; it is not meant as a positive
control for all biological situations.) More-
over, although in some neurons shown in (1)
TUNEL signal appeared in both the nucleus
and the cytoplasm, in other samples not
shown in (1) TUNEL staining was unequiv-
ocally detected only in the nucleus (Fig. 2,
solid arrows). Both situations are consistent
with the literature.
In summary, Thompson and Sawtell
present no convincing evidence against the
finding in (1) that LAT is an anti-apoptosis
gene. The results presented here clearly show
that Anti-PARP p85 recognizes rabbit p85;
the data in the comment on the Promega
antibody’s lack of reactivity with mouse p85
disagrees with the statements of the kit man-
ufacturer; the assumptions in the comment
regarding the amino acid sequence against
which the p85 antibody was made are incor-
rect; and both PARP and TUNEL staining
have been previously reported in both the
nuclei and the cytoplasm of apoptotic cells.
We note, too, that Thompson and Sawtell did
not attempt to refute a separate key finding of
Perng et al.: that a plasmid expressing LAT
nucleotides 301 to 2659 efficiently blocks
apoptosis in transient transfection assays (1).
(This is particularly interesting, because the
plasmid was originally kindly provided to us
by R. L. Thompson, one of the comment
authors.) These results unequivocally demon-
strated that LAT has a powerful anti-apoptosis
activity—and that alone would suggest that
LAT can block apoptosis in rabbit trigeminal
ganglia.
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Fig. 1. Rabbit PARP p85 is recognized by Pro-
mega Anti-PARP p85 on Western blots. Rabbit
skin cells (RS) and human Jurkat cells were
induced to undergo apoptosis. Equal amounts of
total cell extracts (30 mg of protein) were run
on each lane of a 10% SDS-polyacrylamide gel,
transferred to polyvinylidene difluoride mem-
brane, incubated with Anti-PARP p85 antibody,
washed, incubated with donkey anti-rabbit IgG
conjugated to alkaline phosphatase, and devel-
oped with the reagent BCIP/NBT (Gibco BRL,
Life Technologies, Rockville, Maryland). Lanes:
M, molecular weight markers; Jurkat-C, control
untreated Jurkat cells; Jurkat-S, Jurkat cells in-
duced for apoptosis with staurosporin; Jurkat-F,
Jurkat cells induced for apoptosis with anti-Fas antibody; RS-C, control untreated rabbit skin cells;
and RS-S, rabbit skin cells induced for apoptosis with staurosporin. Arrow indicates the PARP p85
band.
Fig. 2. Photomicrographs of TUNEL-
stained TG sections. (A) Uninfected sec-
tion. (B) Wild-type McKrae (LAT1). (C to
G) dLAT2903 (LAT–). (A) to (C) corre-
spond to figure 1, D to F, of (1); (D) to (G)
are from additional experiments not
shown in (1). Solid arrows indicate some
of the TUNEL-positive neuronal nuclei;
open arrow in (E) shows a TUNEL-nega-
tive neuron. (G) is higher magnification
image of boxed portion of (F).
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